The dose escalation arm had an OS benefit approaching significance. 11 Recently, 10-year follow-up data was released for the H10 trials.
1
—
—
The dose escalation arm had an OS benefit approaching significance. 11 Recently, 10-year follow-up data was released for the H10 trials.